Epilog

Company Overview

Snapshot

Founded in June 2022 by Tal Shapsa Heiman, Or Bar Tal, Dan Ariely, and Ron Sabar, Epilog operates with 11–50 employees. The company has raised $1.3M across two funding rounds. In October 2025, Epilog secured a Seed round from Adama Ventures.

Business overview

Epilog is a Health Tech & Life Sciences company focused on improving the management of life's final chapter, particularly for individuals facing life-threatening medical diagnoses. The company's platform aims to enhance quality of life and reduce the economic burden associated with end-of-life decision-making, specifically addressing high hospital utilization rates in the last year of life. Leveraging behavioral principles and expertise from leading behavioral and palliative experts, Epilog's technology helps users manage medical and critical life decisions in real-time, shifting the focus from disease management to life management. It operates in the Digital Healthcare sector, with a focus on Patient Engagement, and utilizes Mobile and Artificial Intelligence technologies to serve patients, providers, and insurance companies globally, including North America.

Company Intelligence Q&A

When was Epilog founded?

Epilog was founded in June 2022.

Who are the founders of Epilog?

The founders of Epilog are Tal Shapsa Heiman, Or Bar Tal, Dan Ariely, and Ron Sabar.

What is Epilog's primary sector?

Epilog's primary sector is Health Tech & Life Sciences.

How much capital has Epilog raised in total?

Epilog has raised a total of $1.3M.

What is Epilog's primary focus?

Epilog focuses on improving the management of life's final chapter for individuals facing life-threatening medical diagnoses, aiming to enhance quality of life and reduce economic burdens.